Press Releases

BUFFALO, N.Y. — Roswell Park’s Marketing/Creative Services team received two international and six national awards for excellence in video production and storytelling. They were honored for two videos that were conceptualized, written and created in-house.

In a new study published today in PLOS Genetics, Christine Ambrosone, PhD, of Roswell Park Comprehensive Cancer Center and colleagues identified a genetic difference between people with African and European ancestry that affects how the immune system triggers inflammation. They suspect these differences are rooted in how the immune system evolved and the evolutionary pressure exerted by malaria on ancestors who lived in Africa.

Roswell Park Comprehensive Cancer Center researchers have identified significant differences in the immune microenvironment of breast cancer tumors between African-American and white women, shedding light on the ways in which race can influence cancer development and outcomes.

CHICAGO — Research from Roswell Park Comprehensive Cancer Center suggests that a new treatment combination can extend survival for many patients with advanced colorectal cancer.

Roswell Park Comprehensive Cancer Center has been approved to administer Kymriah. It’s the first FDA-approved CAR T-cell therapy that’s designed to help a patient’s immune system fight cancer. The cutting-edge treatment is also breaking ground as the first CAR T-cell therapy approved by the FDA to treat two types of cancer, lymphoma and leukemia.